{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:07:55Z","timestamp":1790734075229,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":804,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1093\/annonc\/mdx445","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T15:14:07Z","timestamp":1504192447000},"page":"viii8-viii12","source":"Crossref","is-referenced-by-count":83,"special_numbering":"S8","title":["The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications"],"prefix":"10.1016","volume":"28","author":[{"given":"L.R.","family":"Duska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdx445_bb0010","series-title":"WHO Classification of Tumors of the Female Reproductive Organs","author":"Kurman","year":"2014"},{"key":"10.1093\/annonc\/mdx445_bb0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00404-016-4035-8","article-title":"The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications","volume":"293","author":"Meinhold-Heerlein","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1093\/annonc\/mdx445_bb0020","doi-asserted-by":"crossref","first-page":"1367.","DOI":"10.1007\/s00404-016-4073-2","article-title":"Erratum to: the new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications","volume":"293","author":"Meinhold-Heerlein","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1093\/annonc\/mdx445_bb0025","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/s-0035-1558079","article-title":"Statement by the Kommission Ovar of the AGO: the new FIGO and WHO classifications of ovarian, fallopian tube and primary peritoneal cancer","volume":"75","author":"Meinhold-Heerlein","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1093\/annonc\/mdx445_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1093\/annonc\/mdx445_bb0035","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00404-014-3364-8","article-title":"The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer","volume":"290","author":"Zeppernick","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1093\/annonc\/mdx445_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1093\/annonc\/mdx445_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance","volume":"18","author":"Salani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdx445_bb0050","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ijc.21845","article-title":"Molecular genetic evidence that endometriosis is a precursor of ovarian cancer","volume":"119","author":"Prowse","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdx445_bb0055","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdx445_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2011.08.008","article-title":"Micropapillary pattern in serous borderline ovarian tumors: does it matter?","volume":"123","author":"Park","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdx445_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1525-1438.2007.00820.x","article-title":"Differences of chemoresistance assay between invasive micropapillary\/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma","volume":"17","author":"Santillan","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdx445_bb0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2007.11.013","article-title":"Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum","volume":"108","author":"Schmeler","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdx445_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2011.10.001","article-title":"The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations","volume":"124","author":"Munksgaard","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdx445_bb0080","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-associated mutations in endometriosis without cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdx445_bb0085","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/IGC.0b013e3181bf8111","article-title":"Lymph node-positive stage IIIC ovarian cancer: a separate entity?","volume":"19","author":"Berek","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/annonc\/mdx445_bb0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2017.03.014","article-title":"Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival","volume":"145","author":"Barber","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdx445_bb0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/annonc\/mdx011","article-title":"Fifth ovarian cancer consensus conference of the Gynecologic Cancer InterGroup: first-line interventions","volume":"28","author":"Karam","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdx445_bb0100","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ajog.2015.10.922","article-title":"Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study","volume":"214","author":"Gueli Alletti","year":"2016","journal-title":"Am J Obstet Gynecol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420346561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420346561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/28\/suppl_8\/viii8\/22295144\/mdx445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:05:20Z","timestamp":1582243520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420346561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":19,"alternative-id":["S0923753420346561"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx445","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}